TrialThe oncologist2021

Apatinib in Combination with S-1 as First-Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single-Arm, Phase II Trial.

Na Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.